Uncovering barriers to the adoption of active cold-chain

Active solutions for temperature-controlled, pharmaceutical air cargo are proven to be more effective in every way. They reduce risk in a hazardous world, cut costs when economies are struggling and boost sustainability at a time when the globe is desperately trying to minimise emissions.

Yet barriers to their adoption remain. It should be a simple decision to begin using them, so why does reticence exist? The answer is complex and perhaps as much to do with human nature as it is rational decision-making.
This paper explores barriers to adoption and suggests ways to overcome them.

Fill in the form below you so we can send you the white paper by email.

 

Was this information helpful?